Cargando…

Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas

The World Health Organization (WHO) grading of gliomas stratifies tumors by histology. However, the aggressiveness of tumors in each grade still shows great heterogeneity. Phosphohistone H3 (pHH3) has been reported as an accurate marker of cells within the mitotic phase of the cell cycle in many kin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ping, Zhang, Chuan-Bao, Yang, Pei, Chen, Jing, Liu, Yu-Qing, Hu, Hui-Min, Huang, Hua, Bao, Zhao-Shi, Zhang, Wei, Kong, Wei-Jia, Jiang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216701/ https://www.ncbi.nlm.nih.gov/pubmed/27323851 http://dx.doi.org/10.18632/oncotarget.7154

Ejemplares similares

Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading
por: Ibrahim, Asmaa, et al.
Publicado: (2022)

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
por: Brunner, A, et al.
Publicado: (2012)

PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors
por: Shin, Yooju, et al.
Publicado: (2015)

Level of phosphohistone H3 among various types of human cancers
por: Sun, Amy, et al.
Publicado: (2012)

Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study
por: Habberstad, Andreas H, et al.
Publicado: (2011)

Pooling analysis on prognostic value of PHH3 expression in cancer patients
por: Hao, Qian, et al.
Publicado: (2018)

The usefulness of immunohistochemistry for phosphohistone H3 as a prognostic factor in myxoid liposarcoma
por: Takazawa, Akira, et al.
Publicado: (2023)

Identification of a differentiation stall in epithelial mesenchymal transition in histone H3–mutant diffuse midline glioma
por: Sanders, Lauren M, et al.
Publicado: (2020)

Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade
por: Mirzaiian, Elham, et al.
Publicado: (2020)

The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
por: Saffar, Hana, et al.
Publicado: (2021)

ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion
por: Zhang, Wenlong, et al.
Publicado: (2015)

The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67
por: Kim, Ji-Ye, et al.
Publicado: (2017)

Wnt3a promotes epithelial–mesenchymal transition, migration, and proliferation of lens epithelial cells
por: Bao, Xiu-li, et al.
Publicado: (2012)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

The prognostic importance of PD-L1, PTEN, PHH3, and KI-67 expressions in invasive breast carcinoma
por: Imamoglu, Eda Hilal, et al.
Publicado: (2022)

Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma
por: Lu, Yu-bao, et al.
Publicado: (2020)

miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC
por: Zhou, Dan-Dan, et al.
Publicado: (2021)

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
por: Skaland, Ivar, et al.
Publicado: (2009)

THU105 PHH Parameters Are New Minimal-Invasive Markers Of Glycemic Homeostasis Of Type 1 Diabetes
por: Harvengt, Antoine
Publicado: (2023)

Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors
por: Kim, Min Jeong, et al.
Publicado: (2018)

JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis
por: Zou, Shuang, et al.
Publicado: (2019)

WNK3 promotes the invasiveness of glioma cell lines under hypoxia by inducing the epithelial-to-mesenchymal transition
por: Wang, Yue, et al.
Publicado: (2021)

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression
por: He, Xin, et al.
Publicado: (2023)

STAT3 and epithelial–mesenchymal transitions in carcinomas
por: Wendt, Michael K, et al.
Publicado: (2014)

Upregulation of TrkB Promotes Epithelial-Mesenchymal Transition and Anoikis Resistance in Endometrial Carcinoma
por: Bao, Wei, et al.
Publicado: (2013)

Metadherin regulates epithelial–mesenchymal transition in carcinoma
por: Wang, Zhao, et al.
Publicado: (2016)

The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activity index
por: Tancredi-Cueto, Natalia, et al.
Publicado: (2022)

Mitotic Activity in Gastrointestinal Stromal Tumors: Can we use Phosphohistone H3 Immunohistochemistry Instead of Hematoxylin and Eosin for Mitotic Count?
por: Erhan, Selma Sengiz, et al.
Publicado: (2022)

Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma
por: Chen, Daliang, et al.
Publicado: (2019)

Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in Glioblastoma
por: Takashima, Yasuo, et al.
Publicado: (2019)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
por: Kong, Dejuan, et al.
Publicado: (2012)

Epithelial-Mesenchymal Transition in tumor microenvironment
por: Jing, Yingying, et al.
Publicado: (2011)

Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
por: Guo, Fei, et al.
Publicado: (2014)

Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma
por: Nielsen, Patricia Switten, et al.
Publicado: (2016)

Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early‐stage luminal breast cancer
por: van Steenhoven, Julia E C, et al.
Publicado: (2020)

Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human Glioma
por: Lv, Qiao-Li, et al.
Publicado: (2016)

Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer
por: Chen, Jia, et al.
Publicado: (2014)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
por: Ladstein, Rita G, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_smbg1qg3ltlj3bgn1g89akofqd